• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对 45 岁及以上研究中男性前列腺癌病理诊断和手术数据的描述性分析。

Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.

机构信息

Faculty of Medicine and Health, Sydney School of Public Health, Camperdown, NSW, Australia; The Daffodil Centre, University of Sydney, Sydney, NSW, Australia.

Faculty of Medicine and Health, Sydney School of Public Health, Camperdown, NSW, Australia; The Daffodil Centre, University of Sydney, Sydney, NSW, Australia.

出版信息

Pathology. 2024 Feb;56(1):39-46. doi: 10.1016/j.pathol.2023.09.011. Epub 2023 Nov 21.

DOI:10.1016/j.pathol.2023.09.011
PMID:38104002
Abstract

Information available from the New South Wales Cancer Registry (NSWCR) about the aggressiveness of prostate cancer is limited to the summary stage variable 'degree of spread', which contains a high proportion of cases defined as 'unknown'. In this study we demonstrate the feasibility of obtaining and analysing prostate cancer pathology data from stored pathology records. Pathology data were extracted from stored pathology records of incident prostate cancer cases in men participating in the 45 and Up Study, a large Australian prospective cohort study, who were diagnosed between January 2006 and December 2013. Baseline questionnaires from the 45 and Up Study were linked to the NSWCR. Demographic and pathology items were tabulated and associations described. We evaluated the completeness of pathological characteristics by degree of spread of cancer at diagnosis. Among the 123,921 men enrolled in the 45 and Up Study, 5,091 had incident prostate cancer and 5,085 were linked to a pathology record. The most complete variables included grade group of diagnostic (85.8%) and surgical (99.8%) specimens, margin status (98.1%), extraprostatic extension (95.1%) and seminal vesicle invasion (96.8%). Most diagnostic specimens were grade group 1 (26.6%) or 2 (23.5%). Of the 5,085 cases, 30.8% were classified by the NSWCR with unknown degree of spread; a pathology record could be extracted for 99.4% of these. The unknown degree of spread cases had similar levels of completeness and distribution of diagnostic and surgical pathology features to those with a localised degree of spread. This study demonstrated the feasibility of obtaining and analysing data derived from pathology reports from centralised state-based cancer registry notifications. Supplementing degree of spread information with pathology data from diagnosis and surgery will improve both the quality of research and policy aimed at improving the lives of men with prostate cancer.

摘要

从新南威尔士癌症登记处(NSWCR)获得的关于前列腺癌侵袭性的信息仅限于摘要阶段变量“扩散程度”,其中包含很大比例的病例被定义为“未知”。在这项研究中,我们展示了从存储的病理学记录中获取和分析前列腺癌病理学数据的可行性。从参与大型澳大利亚前瞻性队列研究 45 and Up Study 的男性中患有前列腺癌的男性的存储病理学记录中提取了病理学数据,这些男性病例的诊断时间在 2006 年 1 月至 2013 年 12 月之间。将 45 and Up Study 的基线问卷与 NSWCR 联系起来。列出了人口统计学和病理学项目,并描述了关联。我们通过诊断时癌症的扩散程度评估了病理特征的完整性。在 45 and Up Study 中,有 123921 名男性参加,其中有 5091 名男性患有前列腺癌,有 5085 名男性与病理学记录相关。最完整的变量包括诊断(85.8%)和手术(99.8%)标本的分级组、切缘状态(98.1%)、前列腺外扩展(95.1%)和精囊侵犯(96.8%)。大多数诊断标本的分级组为 1(26.6%)或 2(23.5%)。在 5085 例病例中,有 30.8%的病例被 NSWCR 归类为未知的扩散程度,其中 99.4%的病例可以提取病理学记录。未知扩散程度的病例与局部扩散程度的病例具有相似的完整程度和诊断及手术病理特征分布。本研究证明了从中央州级癌症登记处通知中获取和分析来自病理学报告的数据的可行性。用诊断和手术的病理学数据补充扩散程度信息,将提高针对改善前列腺癌男性生活的研究和政策的质量。

相似文献

1
Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.对 45 岁及以上研究中男性前列腺癌病理诊断和手术数据的描述性分析。
Pathology. 2024 Feb;56(1):39-46. doi: 10.1016/j.pathol.2023.09.011. Epub 2023 Nov 21.
2
Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.癌症相关住院治疗与“未知”分期前列腺癌:一项基于人群的记录链接研究。
BMJ Open. 2017 Jan 11;7(1):e014259. doi: 10.1136/bmjopen-2016-014259.
3
Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.评估澳大利亚新南威尔士癌症登记处的改良-AJCC TNM 分期系统。
BMC Cancer. 2019 Aug 28;19(1):850. doi: 10.1186/s12885-019-6062-x.
4
Detailed breast cancer pathology data for large-scale studies - access and completeness in NSW, Australia.详细的乳腺癌病理学数据用于大规模研究 - 在澳大利亚新南威尔士州的获取和完整性。
Public Health Res Pract. 2021 Dec 2;31(5):31012101. doi: 10.17061/phrp31012101.
5
Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.2级前列腺癌患者“低风险”队列的特征:来自共享平等访问区域癌症医院数据库的结果。
Int J Urol. 2017 Aug;24(8):611-617. doi: 10.1111/iju.13387. Epub 2017 Jun 6.
6
Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.主动监测初始治疗后延迟根治性前列腺切除术的长期结果。
J Urol. 2018 Oct;200(4):779-785. doi: 10.1016/j.juro.2018.04.078. Epub 2018 May 3.
7
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.活检核心特征是预测低级别前列腺癌患者不良病理的不良指标。
J Urol. 2018 Apr;199(4):961-968. doi: 10.1016/j.juro.2017.10.010. Epub 2017 Oct 10.
8
Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.对于当代 Gleason 评分 6 级前列腺癌,前列腺外延伸极为罕见。
Eur Urol. 2017 Sep;72(3):455-460. doi: 10.1016/j.eururo.2016.11.028. Epub 2016 Dec 13.
9
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active Surveillance.前列腺根治性切除术时单纯 Gleason 评分 3+3=6(分级分组 1)癌的前列腺外延伸发生率:对是否应将 Gleason 评分 6 前列腺癌重新命名为“非癌”以及主动监测选择标准的影响。
J Urol. 2018 Jun;199(6):1482-1487. doi: 10.1016/j.juro.2017.11.067. Epub 2017 Nov 15.
10
Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.基于根治性前列腺切除术后不良病理对中危前列腺癌进行亚型分类以用于主动监测。
J Urol. 2018 Nov;200(5):1068-1074. doi: 10.1016/j.juro.2018.04.058. Epub 2018 Apr 17.